You are here

  • Home
  • Archive
  • Volume 9, Issue 9
  • High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

 

Online download statistics by month:

Online download statistics by month: September 2021 to March 2024

AbstractFullPdf
Sep 202110191021296
Oct 202122922880
Nov 202117117147
Dec 202110110242
Jan 2022868743
Feb 2022747674
Mar 202210811056
Apr 2022808241
May 20229810057
Jun 2022838537
Jul 2022858531
Aug 202211912125
Sep 202215115342
Oct 202214214241
Nov 2022737333
Dec 2022505032
Jan 2023717853
Feb 2023727221
Mar 2023454733
Apr 2023424219
May 2023505429
Jun 2023848549
Jul 2023454532
Aug 2023515231
Sep 2023454524
Oct 2023383858
Nov 2023505030
Dec 2023595949
Jan 2024333421
Feb 2024484830
Mar 2024626389
Total346434981545